ES2709298B2 - Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento - Google Patents

Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento Download PDF

Info

Publication number
ES2709298B2
ES2709298B2 ES201731210A ES201731210A ES2709298B2 ES 2709298 B2 ES2709298 B2 ES 2709298B2 ES 201731210 A ES201731210 A ES 201731210A ES 201731210 A ES201731210 A ES 201731210A ES 2709298 B2 ES2709298 B2 ES 2709298B2
Authority
ES
Spain
Prior art keywords
procedure
methyl
piridin
benzodiazepin
imidazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES201731210A
Other languages
English (en)
Other versions
ES2709298A1 (es
Inventor
Casals Carles Sanchez
Rodriguez Alicia Dobarro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Moehs Iberica SL
Original Assignee
Moehs Iberica SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Moehs Iberica SL filed Critical Moehs Iberica SL
Priority to ES201731210A priority Critical patent/ES2709298B2/es
Priority to US16/754,821 priority patent/US11325911B2/en
Priority to PCT/EP2018/077669 priority patent/WO2019072944A1/en
Priority to EP18788710.4A priority patent/EP3694859A1/en
Publication of ES2709298A1 publication Critical patent/ES2709298A1/es
Application granted granted Critical
Publication of ES2709298B2 publication Critical patent/ES2709298B2/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES201731210A 2017-10-13 2017-10-13 Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento Active ES2709298B2 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES201731210A ES2709298B2 (es) 2017-10-13 2017-10-13 Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento
US16/754,821 US11325911B2 (en) 2017-10-13 2018-10-11 Method for preparing 3-[(4S)-8-bromo-1-methyl-6-(pyridin-2-yl)-4H-imidazo[ 1,2-a][1,4]benzodiazepin-4-yl]-propionic acid methyl ester, and compounds useful in said method
PCT/EP2018/077669 WO2019072944A1 (en) 2017-10-13 2018-10-11 PROCESS FOR THE PREPARATION OF 3 - [(4S) -8-BROMO-1-METHYL-6- (PYRIDIN-2-YL) -4H-IMIDAZO [1,2-A] [1,4] METHYL ESTER METHYL ESTER BENZODIAZEPIN-4-YL] -PROPIONIC AND COMPOUNDS USEFUL IN SAID PROCESS
EP18788710.4A EP3694859A1 (en) 2017-10-13 2018-10-11 Method for preparing 3-[(4s)-8-bromo-1-methyl-6-(pyridin-2-yl)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-yl]-propionic acid methyl ester, and compounds useful in said method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201731210A ES2709298B2 (es) 2017-10-13 2017-10-13 Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento

Publications (2)

Publication Number Publication Date
ES2709298A1 ES2709298A1 (es) 2019-04-15
ES2709298B2 true ES2709298B2 (es) 2019-08-21

Family

ID=63878652

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201731210A Active ES2709298B2 (es) 2017-10-13 2017-10-13 Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento

Country Status (4)

Country Link
US (1) US11325911B2 (es)
EP (1) EP3694859A1 (es)
ES (1) ES2709298B2 (es)
WO (1) WO2019072944A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4086260A1 (en) 2017-02-09 2022-11-09 Assia Chemical Industries Ltd. Solid state forms of remimazolam salts
ES2697918A1 (es) * 2017-07-28 2019-01-29 Moehs Iberica Sl Procedimiento para preparar ester metilico del acido 3-[(3s)-7-bromo-2-oxo-5-(piridin-2-il)-2,3-dihidro-1h-[1,4]-benzodiazepin-3-il] propionico, y compuestos utiles en ese procedimiento
ES2709298B2 (es) 2017-10-13 2019-08-21 Moehs Iberica Sl Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento
ES2803099B2 (es) 2019-07-22 2021-11-08 Moehs Iberica Sl Procedimiento de obtención de besilato de remimazolam amorfo
ES2827125A1 (es) * 2019-11-19 2021-05-19 Moehs Iberica Sl Intermedio util en la preparacion de remimazolam, su procedimiento de obtencion, y su uso en la obtencion de remimazolam
CN114644612B (zh) * 2020-12-17 2023-04-28 成都苑东生物制药股份有限公司 一种苯二氮杂类神经抑制剂中间体化合物的制备方法
CN114014839A (zh) * 2021-12-16 2022-02-08 上海再启生物技术有限公司 一种制备瑞马唑仑关键中间体的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001261A (en) 1975-10-20 1977-01-04 The Upjohn Company Process for the production of 1-[(dimethylamino)methyl]-6-phenyl-4H-imidazo[1,2-a][1,4]-benzodiazepine
GB9911152D0 (en) 1999-05-14 1999-07-14 Glaxo Group Ltd Short-acting benzodiazepines
EP2305647A1 (en) 2009-09-18 2011-04-06 PAION UK Limited Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
AR094963A1 (es) * 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
EP4086260A1 (en) * 2017-02-09 2022-11-09 Assia Chemical Industries Ltd. Solid state forms of remimazolam salts
ES2697918A1 (es) * 2017-07-28 2019-01-29 Moehs Iberica Sl Procedimiento para preparar ester metilico del acido 3-[(3s)-7-bromo-2-oxo-5-(piridin-2-il)-2,3-dihidro-1h-[1,4]-benzodiazepin-3-il] propionico, y compuestos utiles en ese procedimiento
ES2709298B2 (es) 2017-10-13 2019-08-21 Moehs Iberica Sl Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento

Also Published As

Publication number Publication date
EP3694859A1 (en) 2020-08-19
US11325911B2 (en) 2022-05-10
ES2709298A1 (es) 2019-04-15
WO2019072944A1 (en) 2019-04-18
US20200239477A1 (en) 2020-07-30

Similar Documents

Publication Publication Date Title
ES2709298B2 (es) Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento
HUE053175T2 (hu) ACC-gátló észterek és azok alkalmazása
BR112016000937A2 (pt) formulações farmacêuticas de pó seco, método para a fabricação de uma formulação de pó seco e uso de uma formulação farmacêutica de pó seco
PT3258962T (pt) Composições mistas de alergénios e métodos para a utilização das mesmas
EP3321271A4 (en) PROCESS FOR THE PRODUCTION OF THE 7H-PYROLLO [2,3-D] PYRIMIDINE DERIVATIVE AND THE CORRESPONDING INTERMEDIATE
PL3271413T3 (pl) Kwasy estryfikowane do stosowania w materiałach polimerowych
MA41977A (fr) Imidazopyrazinones utilisées comme inhibiteurs de pde1
PT2964215T (pt) Mistura de ácidos gordos para utilização no tratamento de patologias inflamatórias
EP3395329A4 (en) METHOD OF PREPARING LIPID BODY AND USE THEREOF
EP3375865A4 (en) THREE DIMENSIONAL FIBROBLAST AGGREGATE AND IN VITRO 3D SKIN MODEL THEREOF
EP3554435A4 (en) SYSTEMS AND METHODS FOR DELIVERY OF MEDICINAL PRODUCTS TO RETINAL TISSUE
IL250271A0 (en) A mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies
PT3041475T (pt) Compostos baseados em pirazolo[1,5-a]pirimidina, composições compreendendo-os e métodos da sua utilização
SG11201803022TA (en) Compositions comprising fatty acids and their use
MA52644A (fr) Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation
IL257143A (en) Cetylated fatty acids, a system for their preparation and use
ES2699722R1 (es) Composicion para tratar enfermedades de las neuronas motoras y uso de la misma
MA40524A (fr) Dérivés d'adrénomédulline stabilisés et leur utilisation
ZA201705530B (en) 6-morpholinyl-2-pyrazolyl-9h-purine derivatives and their use as pi3k inhibitors
EP2968209A4 (en) METADICHOL-R LIQUID AND GELNANOPARTICLE FORMULATIONS
EP3334717A4 (en) ARYL SUBSIDIATED DIHYDROCHINOLINONE, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS
GB201307082D0 (en) Pharmaceutical composition comprising 15-HETrE and methods of using the same
BR112017007754A2 (pt) composições de ácido graxo monoinsaturado e uso para o tratamento de aterosclerose.
PT3177283T (pt) Composto ativo e composição relacionada pata utilização dermatológica no campo farmacêutico ou cosmético
CO7000749A2 (es) Método y programa de compuradora para monitorear el uso de un producto absorbente

Legal Events

Date Code Title Description
BA2A Patent application published

Ref document number: 2709298

Country of ref document: ES

Kind code of ref document: A1

Effective date: 20190415

FG2A Definitive protection

Ref document number: 2709298

Country of ref document: ES

Kind code of ref document: B2

Effective date: 20190821